Synopsis
This report illustrates how Kable Market Research expects the top ICT spenders in the UK Pharmaceutical Industry to allocate their ICT budgets across the core areas of enterprise ICT spend, namely hardware, software, IT services, communications and consulting.
Scope
Identify the top ICT spenders in the UK Pharmaceutical Industry.
Gain a view as to how each top spender in the UK Pharmaceutical Industry allocates its ICT by IT function.
Get a detailed breakdown of estimated budget allocation of top spenders in the UK Pharmaceutical Industry within each of the core areas of ICT spend (hardware, software, IT Services, telecommunications & consulting).
Summary
Why was the report written?
This report presents the output from Kable Market Research’s ICT spend prediction statistical model, a log-linear regression model that provides ICT spending predictions based on a company’s demographic profile. The statistical model has been developed using an extensive collection of survey and interview data Kable Market Research has conducted with ICT decision makers on their ICT spending, as well as the insight of our analyst team.
What makes this report unique and essential to read?
The predictions were formulated in November 2012 following a large survey of ICT decision makers. Estimated trends in ICT spending have been identified through to the end of 2013 following feedback from respondents on their forthcoming investment plans.
Reasons To Buy
NA
Table of Contents
1 Top-level ICT budget breakdowns
1.1 Introduction
2 Top ICT spenders
3 AstraZeneca
3.1 Estimated ICT budget breakdown by function
3.2 Estimated external ICT budget allocation by core technology area
3.3 Detailed ICT budget allocations
3.3.1 Estimated hardware budget breakdown
3.3.2 Estimated software budget breakdown by technology
3.3.3 Estimated software budget breakdown by type
3.3.4 Estimated IT services budget breakdown
3.3.5 Estimated IT consulting services budget breakdown
3.3.6 Estimated telecommunications budget breakdown
4 GlaxoSmithKline
4.1 Estimated ICT budget breakdown by function
4.2 Estimated external ICT budget allocation by core technology area
4.3 Detailed ICT budget allocations
4.3.1 Estimated hardware budget breakdown
4.3.2 Estimated software budget breakdown by technology
4.3.3 Estimated software budget breakdown by type
4.3.4 Estimated IT services budget breakdown
4.3.5 Estimated IT consulting services budget breakdown
4.3.6 Estimated telecommunications budget breakdown
5 Shire Plc
5.1 Estimated ICT budget breakdown by function
5.2 Estimated external ICT budget allocation by core technology area
5.3 Detailed ICT budget allocations
5.3.1 Estimated hardware budget breakdown
5.3.2 Estimated software budget breakdown by technology
5.3.3 Estimated software budget breakdown by type
5.3.4 Estimated IT services budget breakdown
5.3.5 Estimated IT consulting services budget breakdown
5.3.6 Estimated telecommunications budget breakdown
6 Hikma Pharmaceuticals
6.1 Estimated ICT budget breakdown by function
6.2 Estimated external ICT budget allocation by core technology area
6.3 Detailed ICT budget allocations
6.3.1 Estimated hardware budget breakdown
6.3.2 Estimated software budget breakdown by technology
6.3.3 Estimated software budget breakdown by type
6.3.4 Estimated IT services budget breakdown
6.3.5 Estimated IT consulting services budget breakdown
6.3.6 Estimated telecommunications budget breakdown
7 Dechra Pharmaceuticals
7.1 Estimated ICT budget breakdown by function
7.2 Estimated external ICT budget allocation by core technology area
7.3 Detailed ICT budget allocations
7.3.1 Estimated hardware budget breakdown
7.3.2 Estimated software budget breakdown by technology
7.3.3 Estimated software budget breakdown by type
7.3.4 Estimated IT services budget breakdown
7.3.5 Estimated IT consulting services budget breakdown
7.3.6 Estimated telecommunications budget breakdown
8 Genus Plc
8.1 Estimated ICT budget breakdown by function
8.2 Estimated external ICT budget allocation by core technology area
8.3 Detailed ICT budget allocations
8.3.1 Estimated hardware budget breakdown
8.3.2 Estimated software budget breakdown by technology
8.3.3 Estimated software budget breakdown by type
8.3.4 Estimated IT services budget breakdown
8.3.5 Estimated IT consulting services budget breakdown
8.3.6 Estimated telecommunications budget breakdown
9 NAPP Pharmaceuticals
9.1 Estimated ICT budget breakdown by function
9.2 Estimated external ICT budget allocation by core technology area
9.3 Detailed ICT budget allocations
9.3.1 Estimated hardware budget breakdown
9.3.2 Estimated software budget breakdown by technology
9.3.3 Estimated software budget breakdown by type
9.3.4 Estimated IT services budget breakdown
9.3.5 Estimated IT consulting services budget breakdown
9.3.6 Estimated telecommunications budget breakdown
10 BTG Plc
10.1 Estimated ICT budget breakdown by function
10.2 Estimated external ICT budget allocation by core technology area
10.3 Detailed ICT budget allocations
10.3.1 Estimated hardware budget breakdown
10.3.2 Estimated software budget breakdown by technology
10.3.3 Estimated software budget breakdown by type
10.3.4 Estimated IT services budget breakdown
10.3.5 Estimated IT consulting services budget breakdown
10.3.6 Estimated telecommunications budget breakdown
11 Aesica Pharmaceuticals
11.1 Estimated ICT budget breakdown by function
11.2 Estimated external ICT budget allocation by core technology area
11.3 Detailed ICT budget allocations
11.3.1 Estimated hardware budget breakdown
11.3.2 Estimated software budget breakdown by technology
11.3.3 Estimated software budget breakdown by type
11.3.4 Estimated IT services budget breakdown
11.3.5 Estimated IT consulting services budget breakdown
11.3.6 Estimated telecommunications budget breakdown
12 NextPharma
12.1 Estimated ICT budget breakdown by function
12.2 Estimated external ICT budget allocation by core technology area
12.3 Detailed ICT budget allocations
12.3.1 Estimated hardware budget breakdown
12.3.2 Estimated software budget breakdown by technology
12.3.3 Estimated software budget breakdown by type
12.3.4 Estimated IT services budget breakdown
12.3.5 Estimated IT consulting services budget breakdown
12.3.6 Estimated telecommunications budget breakdown
13 Appendix
13.1 Definitions
13.2 Further reading
13.3 Contact the authors
List Of Tables
Table 1: Top ICT spenders in the UK pharmaceutical industry
Table 2: AstraZeneca will spend an estimated £164m on its data centre
Table 3: AstraZeneca will spend an estimated £164m on hardware
Table 4: AstraZeneca will spend an estimated £29m on clients
Table 5: AstraZeneca will spend an estimated £26m on enterprise applications
Table 6: AstraZeneca will spend an estimated £51m on software licenses
Table 7: AstraZeneca will spend an estimated £24m on application development & integration
Table 8: AstraZeneca will spend an estimated £27m on systems planning & design
Table 9: AstraZeneca will spend an estimated £22m on fixed voice
Table 10: GlaxoSmithKline will spend an estimated £161m on its data centre
Table 11: GlaxoSmithKline will spend an estimated £162m on hardware
Table 12: GlaxoSmithKline will spend an estimated £29m on clients
Table 13: GlaxoSmithKline will spend an estimated £25m on enterprise applications
Table 14: GlaxoSmithKline will spend an estimated £50m on software licenses
Table 15: GlaxoSmithKline will spend an estimated £23m on application development & integration
Table 16: GlaxoSmithKline will spend an estimated £27m on systems planning & design
Table 17: GlaxoSmithKline will spend an estimated £21m on fixed voice
Table 18: Shire Plc will spend an estimated £25m on its data centre
Table 19: Shire Plc will spend an estimated £26m on hardware
Table 20: Shire Plc will spend an estimated £5m on clients
Table 21: Shire Plc will spend an estimated £4m on enterprise applications
Table 22: Shire Plc will spend an estimated £8m on software licenses
Table 23: Shire Plc will spend an estimated £4m on application development & integration
Table 24: Shire Plc will spend an estimated £4m on systems planning & design
Table 25: Shire Plc will spend an estimated £3m on fixed voice
Table 26: Hikma Pharmaceuticals will spend an estimated £6m on its data centre
Table 27: Hikma Pharmaceuticals will spend an estimated £6m on hardware
Table 28: Hikma Pharmaceuticals will spend an estimated £1m on clients
Table 29: Hikma Pharmaceuticals will spend an estimated £1m on enterprise applications
Table 30: Hikma Pharmaceuticals will spend an estimated £2m on software licenses
Table 31: Hikma Pharmaceuticals will spend an estimated £1m on application development & integration
Table 32: Hikma Pharmaceuticals will spend an estimated £1m on systems planning & design
Table 33: Hikma Pharmaceuticals will spend an estimated £1m on fixed voice
Table 34: Dechra Pharmaceuticals will spend an estimated £3m on its data centre
Table 35: Dechra Pharmaceuticals will spend an estimated £3m on hardware
Table 36: Dechra Pharmaceuticals will spend an estimated £1m on clients
Table 37: Dechra Pharmaceuticals will spend an estimated £0.5m on application lifecycle
Table 38: Dechra Pharmaceuticals will spend an estimated £1m on software licenses
Table 39: Dechra Pharmaceuticals will spend an estimated £0.4m on application development & integration
Table 40: Dechra Pharmaceuticals will spend an estimated £0.5m on systems planning & design
Table 41: Dechra Pharmaceuticals will spend an estimated £0.4m on fixed voice
Table 42: Genus Plc will spend an estimated £3m on its data centre
Table 43: Genus Plc will spend an estimated £3m on hardware
Table 44: Genus Plc will spend an estimated £0.5m on clients
Table 45: Genus Plc will spend an estimated £0.4m on application lifecycle
Table 46: Genus Plc will spend an estimated £1m on software licenses
Table 47: Genus Plc will spend an estimated £0.4m on application development & integration
Table 48: Genus Plc will spend an estimated £0.4m on systems planning & design
Table 49: Genus Plc will spend an estimated £0.3m on fixed voice
Table 50: NAPP Pharmaceuticals will spend an estimated £2m on its data centre
Table 51: NAPP Pharmaceuticals will spend an estimated £2m on hardware
Table 52: NAPP Pharmaceuticals will spend an estimated £0.4m on clients
Table 53: NAPP Pharmaceuticals will spend an estimated £0.3m on enterprise applications
Table 54: NAPP Pharmaceuticals will spend an estimated £1m on software licenses
Table 55: NAPP Pharmaceuticals will spend an estimated £0.3m on application development & integration
Table 56: NAPP Pharmaceuticals will spend an estimated £0.3m on systems planning & design
Table 57: NAPP Pharmaceuticals will spend an estimated £0.3m on fixed voice
Table 58: BTG Plc will spend an estimated £2m on its data centre
Table 59: BTG Plc will spend an estimated £2m on hardware
Table 60: BTG Plc will spend an estimated £0.3m on clients
Table 61: BTG Plc will spend an estimated £0.3m on enterprise applications
Table 62: BTG Plc will spend an estimated £1m on software licenses
Table 63: BTG Plc will spend an estimated £0.2m on application development & integration
Table 64: BTG Plc will spend an estimated £0.3m on systems planning & design
Table 65: BTG Plc will spend an estimated £0.2m on fixed voice
Table 66: Aesica Pharmaceuticals will spend an estimated £1m on its data centre
Table 67: Aesica Pharmaceuticals will spend an estimated £1m on hardware
Table 68: Aesica Pharmaceuticals will spend an estimated £0.2m on clients
Table 69: Aesica Pharmaceuticals will spend an estimated £0.2m on enterprise applications
Table 70: Aesica Pharmaceuticals will spend an estimated £0.3m on software licenses
Table 71: Aesica Pharmaceuticals will spend an estimated £0.1m on application development & integration
Table 72: Aesica Pharmaceuticals will spend an estimated £0.2m on systems planning & design
Table 73: Aesica Pharmaceuticals will spend an estimated £0.1m on fixed voice
Table 74: NextPharma will spend an estimated £1m on its data centre
Table 75: NextPharma will spend an estimated £1m on hardware
Table 76: NextPharma will spend an estimated £0.2m on clients
Table 77: NextPharma will spend an estimated £0.2m on enterprise applications
Table 78: NextPharma will spend an estimated £0.3m on software licenses
Table 79: NextPharma will spend an estimated £0.1m on application development & integration
Table 80: NextPharma will spend an estimated £0.2m on systems planning & design
Table 81: NextPharma will spend an estimated £0.1m on fixed voice
List Of Figures
Figure 1: Top ICT spenders in the UK pharmaceutical industry
